Comron Hassanzadeh, MD, MPH

Dr. Comron Hassanzadeh is an Assistant Professor of Radiation Oncology at The University of Texas MD Anderson Cancer Center and Bone Metastasis Clinic Director where he specializes in the management of patients with prostate, bladder, kidney, testicular cancers, and patients with bone metastases. Prior to his appointment, he earned his medical degree from the University of Missouri Kansas City. He then completed a residency in Radiation Oncology at Washington University School of Medicine. During residency, he completed a Master of Public Health at the University of Missouri.

Dr. Hassanzadeh has clinical expertise in a variety of radiation modalities including intensity modulated radiation (IMRT), proton therapy, stereotactic body radiation therapy (SBRT), LDR and HDR brachytherapy, magnetic resonance guided radiation, and online adaptive radiation. He serves as the Principal Investigator on both prostate and bladder cancer trials aiming to define clinical practice. He has received extramural research support and his research has been presented at national/international conferences and published in high-impact, peer-reviewed journals. In addition, he has authored national guidelines for the management of prostate and bladder cancer through committee service in the American Radium Society, American Society for Therapeutic Radiation Oncology, and International Bladder Cancer Group.

He currently serves in various leadership roles within organizations including NRG Oncology, American College of Radiation Oncology, American Society for Therapeutic Radiation Oncology, ECOG-ACRIN, International Bladder Cancer Group, Bladder Cancer Advocacy Network, Radiological Society of North America, American Radium Society, and American College of Radiology.

Disclosures:

• Employment: MD Anderson:Assistant Prof:Employee
• Compensation: Myriad Genetics: Research Grants, Research Funding, Research Salary Support,Grant Research Funding-End Date: 6/1/2025
• Ownership: none
• Leadership: none